| A review of hydrogen sulfide (H2S) donors: Chemistry and potential therapeutic applications |
59 |
| The P2X7 receptor: A main player in inflammation |
41 |
| Modulating autophagy in cancer therapy: Advancements and challenges for cancer cell death sensitization |
40 |
| Polyphenols, food and pharma. Current knowledge and directions for future research |
34 |
| A timeline of hydrogen sulfide (H2S) research: From environmental toxin to biological mediator |
34 |
| The macrophage heme-heme oxygenase-1 system and its role in inflammation |
34 |
| A delicate balance - The BCL-2 family and its role in apoptosis, oncogenesis, and cancer therapeutics |
32 |
| Chondrocyte dedifferentiation and osteoarthritis (OA) |
26 |
| The therapeutic potential of purinergic signalling |
26 |
| Gasotransmitter hydrogen sulfide signaling in neuronal health and disease |
26 |
| The wonderland of neuronal nicotinic acetylcholine receptors |
24 |
| Canagliflozin exerts anti-inflammatory effects by inhibiting intracellular glucose metabolism and promoting autophagy in immune cells |
24 |
| H2S and polysulfide metabolism: Conventional and unconventional pathways |
23 |
| The many facets of macrophages in rheumatoid arthritis |
23 |
| Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases |
23 |
| Thrombospondin enhances RANKL-dependent osteoclastogenesis and facilitates lung cancer bone metastasis |
22 |
| Puerarin reverses cadmium-induced lysosomal dysfunction in primary rat proximal tubular cells via inhibiting Nrf2 pathway |
22 |
| Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats |
22 |
| Thrombospondin 2 promotes tumor metastasis by inducing matrix metalloproteinase-13 production in lung cancer cells |
21 |
| Osteoarthritis phenotypes and novel therapeutic targets |
21 |
| Human GIP(3-30)NH2 inhibits G protein-dependent as well as G protein-independent signaling and is selective for the GIP receptor with high-affinity binding to primate but not rodent GIP receptors |
20 |
| Dormant, quiescent, tolerant and persister cells: Four synonyms for the same target in cancer |
20 |
| Ginsenoside Rh4 induces apoptosis and autophagic cell death through activation of the ROS/JNK/p53 pathway in colorectal cancer cells |
20 |
| Aryl hydrocarbon receptor (AHR): From selected human target genes and crosstalk with transcription factors to multiple AHR functions |
19 |
| Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes |
19 |
| Alzheimer's disease (AD) therapeutics-1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality |
19 |
| Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting |
18 |
| Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system |
18 |
| Autophagy inducers in cancer |
17 |
| Quercetin ameliorates kidney injury and fibrosis by modulating M1/M2 macrophage polarization |
17 |
| Resistin facilitates VEGF-C-associated lymphangiogenesis by inhibiting miR-186 in human chondrosarcoma cells |
17 |
| Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide |
17 |
| Hydrogen sulfide in the regulation of insulin secretion and insulin sensitivity: Implications for the pathogenesis and treatment of diabetes mellitus |
17 |
| Drug resistance induces the upregulation of H2S-producing enzymes in HCT116 colon cancer cells |
17 |
| Targeting chronic innate inflammatory pathways, the main road to prevention of osteoarthritis progression |
17 |
| MicroRNA: A new generation therapeutic target in diabetic nephropathy |
16 |
| Nano-delivery systems for encapsulation of dietary polyphenols: An experimental approach for neurodegenerative diseases and brain tumors |
16 |
| Appraising the entourage effect: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer |
16 |
| Ulixertinib (BVD-523) antagonizes ABCB1-and ABCG2-mediated chemotherapeutic drug resistance |
16 |
| Lanatoside C inhibits cell proliferation and induces apoptosis through attenuating Wnt/beta-catenin/c-Myc signaling pathway in human gastric cancer cell |
16 |
| Opening of voltage dependent anion channels promotes reactive oxygen species generation, mitochondrial dysfunction and cell death in cancer cells |
16 |
| Microglia-derived extracellular vesicles in Alzheimer's Disease: A double-edged sword |
15 |
| Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy |
15 |
| Cholinesterases and the fine line between poison and remedy |
15 |
| Monoacylglycerol lipase (MAGL) as a promising therapeutic target |
15 |
| Role of the endocannabinoid system in drug addiction |
15 |
| Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells |
15 |
| Betulinic acid suppresses breast cancer aerobic glycolysis via caveolin-1/NF-kappa B/c-Myc pathway |
15 |
| Role of endogenous and exogenous nitric oxide, carbon monoxide and hydrogen sulfide in HCT116 colon cancer cell proliferation |
15 |
| Cardamonin, a natural flavone, alleviates inflammatory bowel disease by the inhibition of NLRP3 inflammasome activation via an AhR/Nrf2/NQO1 pathway |
15 |
